News for Researchers
Accurexa Announces License For UCSF Brain Stem Cell Device (Bay Street)
(San Francisco, CA) The University of California, San Francisco announced that it has entered into an exclusive license agreement with Accurexa, Inc for global licensing of a medical stereotactic device.
Initial Six Teams to Compete for New Organ Liver Prize (PR Web)
(Washington, DC) Global competition with a $1 million prize for the first team to create a bioengineered solution to survive without native liver function.
Scientists Create Therapy-Grade Stem Cells Using New Cocktail to Reprogram Adult Cells (Phys)
(Jerusalem, Israel) Researchers at the Hebrew University of Jerusalem have developed a new formulation that is highly effective in transforming adult stem cells into quality pluripotent stem cells.
Researchers Discover What Lies Behind the Death of Stem Cells (Imperial)
(London, England) Researchers identify small molecules called microRNA that play a key role in controlling the death and survival of pluripotent stem cells.
Denmark All Set For Human Stem-Cell Trials (CPH Post)
(Copenhagen, Denmark) An advanced group of scientists will begin clinical trials using stem cells for a number of debilitating diseases.
Cleveland BioLabs Announces Approval to Start Phase 1 Study for Hematopoietic Stem Cell Mobilizer in Russian Federation (Market Wired)
(Buffalo, NY) Cleveland BioLabs Inc. receive approval from the Russian Ministry of health to begin phase 1 clinical trials for the induction and mobilization of hematopoietic stem cells.
World’s First AMD Stem Cell Therapy Patient (Optometry)
(Kobe, Japan) IPS cells used to grow retinal tissue in a patient with age-related macular degeneration.
New Method to ‘Reset’ Human Stem Cells (Fierce Biotech Research)
(Cambridge, England) A scientist demonstrated technique for generating human pluripotent stem cells from adult stem cells.
Study Shows How Stem Cells Treat Lung Disease (Medical XPress)
(Munich, Germany) The treatment of acute respiratory distress syndrome (ARDS) with stem cells to minimize inflammation.